Editorial: Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies

Jianmei W. Leavenworth; Xin Lai; Hongming Miao; Di Wang; Huakan Zhao; Yongsheng Li

doi:10.3389/fimmu.2022.1113031

Editorial: Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies

Jianmei W. Leavenworth^*
, Xin Lai^*
, Hongming Miao^*
, Di Wang^*
, Huakan Zhao^*
, Yongsheng Li^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Scientific

1 Citation (Scopus)

13 Downloads (Pure)

Original language	English
Article number	1113031
Number of pages	3
Journal	Frontiers in Immunology
Volume	13
DOIs	https://doi.org/10.3389/fimmu.2022.1113031
Publication status	Published - 16 Dec 2022
Publication type	B1 Journal article

Funding

JWL is supported by the University of Alabama at Birmingham (UAB) faculty start-up funds, DoD W81XWH-18-1-0315, NIH R01AI148711 and NIH R01CA276190. XL receives the funding e:Med MelAutim 01ZX1905A from German Federal Ministry of Education and Research. Acknowledgments

Keywords

cancer immunotherapy
macrophage
tumor immunity
tumor microenvironment
tumor-associated macrophages

ASJC Scopus subject areas

Immunology and Allergy
Immunology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fimmu.2022.1113031Licence: CC BY

fimmu-13-1113031-2Final published version, 368 KBLicence: CC BY

https://urn.fi/URN:NBN:fi:tuni-202307077157Licence: CC BY

Cite this

@article{136ceb5307354e32a9f95b66fd7c8817,

title = "Editorial: Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies",

keywords = "cancer immunotherapy, macrophage, tumor immunity, tumor microenvironment, tumor-associated macrophages",

author = "Leavenworth, \{Jianmei W.\} and Xin Lai and Hongming Miao and Di Wang and Huakan Zhao and Yongsheng Li",

note = "Funding Information: JWL is supported by the University of Alabama at Birmingham (UAB) faculty start-up funds, DoD W81XWH-18-1-0315, NIH R01AI148711 and NIH R01CA276190. XL receives the funding e:Med MelAutim 01ZX1905A from German Federal Ministry of Education and Research. Acknowledgments ",

year = "2022",

month = dec,

day = "16",

doi = "10.3389/fimmu.2022.1113031",

language = "English",

volume = "13",

}

TY - JOUR

T1 - Editorial

T2 - Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies

AU - Leavenworth, Jianmei W.

AU - Lai, Xin

AU - Miao, Hongming

AU - Wang, Di

AU - Zhao, Huakan

AU - Li, Yongsheng

N1 - Funding Information: JWL is supported by the University of Alabama at Birmingham (UAB) faculty start-up funds, DoD W81XWH-18-1-0315, NIH R01AI148711 and NIH R01CA276190. XL receives the funding e:Med MelAutim 01ZX1905A from German Federal Ministry of Education and Research. Acknowledgments

PY - 2022/12/16

Y1 - 2022/12/16

KW - cancer immunotherapy

KW - macrophage

KW - tumor immunity

KW - tumor microenvironment

KW - tumor-associated macrophages

U2 - 10.3389/fimmu.2022.1113031

DO - 10.3389/fimmu.2022.1113031

M3 - Editorial

C2 - 36591256

AN - SCOPUS:85145343711

SN - 1664-3224

VL - 13

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1113031

ER -